Cash transfer for Satisfaction, Personal

Phase-Based Progress Estimates
University of British Columbia, Vancouver, Canada
Satisfaction, Personal+1 More
Cash transfer - Behavioral
All Sexes
What conditions do you have?

Study Summary

The primary goal of the study is to determine the impacts of a one-time unconditional cash transfer on the well-being of people experiencing homelessness.

Eligible Conditions

  • Satisfaction, Personal
  • Homelessness

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

7 Primary · 0 Secondary · Reporting Duration: 1-3 months

1-3 months
Cost of shelter use
Spending on Rent
Spending on temptation goods
Stable housing
Total Spending

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

1 of 2
1 of 2
Active Control
Experimental Treatment

400 Total Participants · 2 Treatment Groups

Primary Treatment: Cash transfer · No Placebo Group · N/A

Experimental Group · 1 Intervention: Cash transfer · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:
First Studied
Drug Approval Stage
How many patients have taken this drug
Cash transfer

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1-3 months
Closest Location: University of British Columbia · Vancouver, Canada
Photo of Vancouver 1Photo of Vancouver 2Photo of Vancouver 3
2004First Recorded Clinical Trial
1 TrialsResearching Satisfaction, Personal
201 CompletedClinical Trials

Who is running the clinical trial?

Foundations for Social ChangeUNKNOWN
University of British ColumbiaLead Sponsor
1,295 Previous Clinical Trials
1,270,607 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are between 18 and 65 years of age.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.